Coronavirus (COVID-19) - Latest Information for Patients and Visitors

(La más reciente información para pacientes y visitantes)

 

Read Now (Lea ahora)
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Dr. Gerard J. Criner, Temple Lung Center Team Perform Nation’s First Post-FDA Approval Implantation of Device to Treat Severe Emphysema

View All News

Gerard J. Criner, MD, FACP, FACCP

On August 10, Temple University Hospital became the first U.S. center to perform bronchoscopic lung volume reduction using implantation of the Zephyr® Endobronchial Valve (Zephyr® EBV®) to treat severe emphysema following U.S. FDA approval. Gerard J. Criner, MD, FACP, FACCP, Chair and Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University and Director of the Temple Lung Center, and his Lung Center team completed the 45-minute procedure. ScienmagBioengineer.orgMedicalXpress and News-Medical.net provided coverage.